ProQR Therapeutics N.V. buy Citigroup Inc.
Start price
10.03.25
/
50%
€1.87
Target price
10.03.26
€3.68
Performance (%)
-20.01%
End price
11.03.26
€1.50
Summary
This prediction ended on 11.03.26 with a price of €1.50. The price of ProQR Therapeutics N.V. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.01%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | -1.911% | -1.911% | -15.292% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by Citigroup_Inc_ for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $4.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.78
19.04.24
19.04.24
€1.88
19.04.25
19.04.25
-36.85%
20.04.25
20.04.25
